<DOC>
	<DOCNO>NCT01037387</DOCNO>
	<brief_summary>Parallel , randomize control clinical trial evaluate effect 12 month noninvasive mechanical ventilation versus conventional treatment hypercapnic patient stable COPD . Main objective : To evaluate effect 12 month noninvasive ventilation c-reactive protein concentration daily physical activity hypercapnic patient stable COPD . Secondary objective : To compare plasmatic concentration inflammatory biomarkers COPD patient conventional treatment wich noninvasive ventilation . To determine response breathlessness , health-related quality life lung function noninvasive ventilation . To identify COPD patient higher gasometric clinic response noninvasive ventilation .</brief_summary>
	<brief_title>Effect Noninvasive Ventilation Physical Activity Inflammation COPD Patients</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Hypercapnia</mesh_term>
	<mesh_term>Bronchodilator Agents</mesh_term>
	<criteria>Age : 4575 yr . COPD diagnosis ( postbronchodilator FEV1/FVC &lt; 0.7 ) least 6 month . FEV1 &lt; 45 % predict Baseline pH 7.357.45 Baseline PaCO2 &gt; 45 mmHg breathe current air Smoking history ( &gt; 15 packyear ) Clinically stable least last three month Pharmacological treatment optimize last two year . Previous diagnosis asthma , airway obstructive disease , sleep apnea syndrome , interstitial lung disease , chest wall disease neuromuscular disease . Apneahypopnea index &gt; 10/h Morbid obesity ( BMI &gt; 45 Kg/m2 ) Previous diagnosis ischaemic heart disease , cardiac failure , cirrhosis , chronic renal failure , rheumatoid arthritis inflammatory disease .</criteria>
	<gender>All</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>